Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 35, Issue 11, 2008, Pages 2265-2271

  Souza, Letícia S ^a   Machado, Sandra H ^a   Brenol, Claiton V ^a   Brenol, João Carlos T ^a   Xavier, Ricardo M ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Growth velocity; Interleukin 6; Juvenile idiopathic arthritis

Indexed keywords

C REACTIVE PROTEIN; GLUCOCORTICOID; INTERLEUKIN 6; SOMATOMEDIN C;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GROWTH RATE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ANTHROPOMETRY; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; CHILD; FEMALE; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMANS; INTERLEUKIN-6; LINEAR MODELS; MALE; PREVALENCE; PUBERTY;

EID: 56449089309     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080199     Document Type: Article

References (49)

1. Motil KJ, Grand RJ, Davis-Kraft L, Ferlic LL, Smith EO. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-91.
2. Sproul A, Huang N. Growth patterns in children with cystic fibrosis. J Pediatr 1964;65:664-76.
3. Ansell BM, Bywaters EG. Growth in Still's disease. Ann Rheum Dis 1956;15:295-319.
4. Liem JJ, Rosenberg AM. Growth patterns in juvenile rheumatoid arthritis. Clin Exp Rheumatol 2003;21:663-8.
5. Garcia-Consuegra Molina J, Merino Munoz R, Lama More R, Coya Vina J, Gracia Bouthelier R. Growth in children with juvenile idiopathic arthritis. An Pediatr Barc 2003;58:529-37.
6. Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM. Effect of inflammatory activity and glucorticoid use on nutritional variables in patients with juvenile idiopathic arthritis. J Rheumatol 2006;33:601-8.
7. Simon D, Fernando C, Czernichow P, Prieur AM. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. J Rheumatol 2002;29:1296-300. [Correction J Rheumatol 2006;33:829]
8. De Benedetti F, Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol 1998;25:203-7.
9. Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20.
10. Kutukculer N, Caglayan S, Aydogdu F. Study of pro-inflammatory (TNF-a, IL-1a, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters. Clin Rheumatol 1998;17:288-92.
11. Ou LS, See LC, Wu CJ, Kao CC, Lin YL, Huang JL. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Clin Rheumatol 2002;21:52-6.
12. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997;15:797-819.
13. Yokota S. Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis. Curr Opin Rheumatol 2003;15:581-6.
14. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-50.
15. Lieskovska J, Guo D, Derman E. Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm IGF Res 2003;13:26-35.
16. De Benedetti F, Meazza C, Martini A. Role of interleukin-6 in growth failure: an animal model. Horm Res 2002;58 Suppl 1:24-7.
17. Lieskovska J, Guo D, Derman E. IL-6-overexpression brings about growth impairment potentially through a GH receptor defect. Growth Horm IGF Res 2002;12:388-98.
18. de Martino M, Galli L, Chiarelli F, et al. Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection. Clin Immunol 2000;94:212-8.
19. Woo P, Wilkinson N, Prieur AM, et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 2005;7:R1281-8.
20. Yokota S, Miyamae T, Imagawa T, et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2005;52:818-25.
21. Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth. J Pediatr Endocrinol Metab 2001;14 Suppl 6:1483-6.
22. Aitman TJ, Palmer RG, Loftus J, et al. Serum IGF-I levels and growth failure in juvenile chronic arthritis. Clin Exp Rheumatol 1989;7:557-61.
23. Saha MT, Verronen P, Laippala P, Lenko HL. Growth of prepubertal children with juvenile chronic arthritis. Acta Paediatr 1999;88:724-8.
24. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
25. Gäre BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process. J Rheumatol 1995;22:295-307.
26. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
27. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
28. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966;41:454-71.
29. Organization WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854.
30. Statistics NCHS. NCHS growth curves for children. Birth - 18 years. United States. Hyattsville, MD: National Center for Health Statistics; 1977. DHEW publication no. (PHS); 78-1650. Vital and health statistics; series 11, no. 165.
31. Statistics NCHS. Anthropometric reference data and prevalence of overweight. United States, 1976-80. Hyattsville, MD: National Center for Health Statistics; 1987. DHEW publication no. (PHS) 87-1688. Vital and health statistics; series 11, no. 238.
32. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child 1966;41:613-35.
33. Miles LE, Lipschitz DA, Bieber CP, Cook JD. Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 1974;61:209-24.
34. Norusis M. SPSS 11.0 guide to data analysis. Upper Saddle River, NJ: Prentice Hall; 2002.
35. Lofthouse CM, Azad F, Baildam EM, Akobeng AK. Measuring the nutritional status of children with juvenile idiopathic arthritis using the bioelectrical impedance method. Rheumatology Oxford 2002;41:1172-7.
36. Polito C, Strano CG, Olivieri AN, et al. Growth retardation in non-steroid treated juvenile rheumatoid arthritis. Scand J Rheumatol 1997;26:99-103.
37. Saxena N, Aggarwal A, Misra R. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J Rheumatol 2005;32:1349-53.
38. Haugen MA, Lien G, Flato B, et al. Minor impact of juvenile arthritis on nutritional status in young adult patients. Arthritis Rheum 2002;47:623-9.
39. Cleary AG, Lancaster GA, Annan F, Sills JA, Davidson JE. Nutritional impairment in juvenile idiopathic arthritis. Rheumatology Oxford 2004;43:1569-73.
40. Chedeville G, Quartier P, Miranda M, Brauner R, Prieur AM. Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity. Joint Bone Spine 2005;72:392-6.
41. Pomeroy C, Eckert E, Hu S, et al. Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol Psychiatry 1994;36:836-9.
42. Bruun JM, Verdich C, Toubro S, Astrup A, Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-a. Effect of weight loss in obese men. Eur J Endocrinol 2003;148:535-42.
43. Carrero JJ, Qureshi AR, Axelsson J, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 2007;85:695-701.
44. Haugen MA, Hoyeraal HM, Larsen S, Gilboe IM, Trygg K. Nutrient intake and nutritional status in children with juvenile chronic arthritis. Scand J Rheumatol 1992;21:165-70.
45. Zak M, Muller J, Karup Pedersen F. Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. A long-term follow-up study. Horm Res 1999;52:80-5.
46. Touati G, Prieur AM, Ruiz JC, Noel M, Czernichow P. Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy. I. Effects on growth velocity and body composition. J Clin Endocrinol Metab 1998;83:403-9.
47. Wang SJ, Yang YH, Lin YT, Yang CM, Chiang BL. Attained adult height in juvenile rheumatoid arthritis with or without corticosteroid treatment. Clin Rheumatol 2002;21:363-8.
48. Ringold S, Wallace CA. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007;19:471-6.
49. Tynjala P, Lahdenne P, Vahasalo P, Kautiainen H, Honkanen V. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis. Ann Rheum Dis 2006;65:1044-9.